eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple endocrine neoplasia type 1 |
| Comorbidity | C0001418|adenocarcinoma |
| Sentences | 6 |
| PubMedID- 20828979 | Purpose: to assess the safety and efficacy of a new neoadjuvant chemoradiation (crt) docetaxel-based regimen in patients with resectable adenocarcinoma of the pancreatic head or body. |
| PubMedID- 20169667 | Little data are available, however, on the use of this regimen in patients with clear cell adenocarcinoma of the ovary (ccc). |
| PubMedID- 22759597 | Tumor response to an s-1 regimen in patients with advanced esophageal adenocarcinoma, however, remains to be elucidated. |
| PubMedID- 21414740 | Background: to investigate the efficacy and toxicity of folfox4 regimen and lv5fu2 regimen in patients with advanced gastric adenocarcinoma after curative gastrectomy. |
| PubMedID- 24473642 | Herein we report the outcomes of an extended neoadjuvant chemotherapy regimen in patients presenting with borderline resectable adenocarcinoma of the pancreatic head. |
| PubMedID- 22540056 | To assess the safety and efficacy of a new neoadjuvant chemoradiation (crt) docetaxel-based regimen in patients with resectable adenocarcinoma of the pancreatic head or body 34 patients with histologically-confirmed resectable pancreatic adenocarcinoma were included in this prospective two-center phase ii study. |
Page: 1